NCT02141776

Brief Summary

Major depressive disorder (MDD) is a significant public health problem. Existing treatment modalities are not always sufficient to alleviate this disorder. Treatment refractoriness is a common clinical problem. Transcranial direct current stimulation (t-DCS), a non-invasive brain stimulation technique, has been shown to be effective in alleviating depressive symptoms in preliminary studies. There is need to explore the role of t-DCS in Treatment-resistant depression (TRD). Therefore, the investigators aim to undertake this exploratory study. Aim: Compare the role of left prefrontal cortex anodal t-DCS daily stimulation of 4 weeks (20 week days) with sham stimulation in alleviating depressive symptoms in patients with TRD. Methodology: Patients who seek treatment in our treatment resistant depression clinic and who have failed to respond to treatment with two antidepressant medications will be offered to enroll in this study. The aim is to study 20 patients who meet the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria for MDD between the ages of 21-65 years. Those subjects that receive sham stimulation will be offered to have active t-DCS stimulation for additional 3 weeks to get any benefit that they may have otherwise missed by being in the sham stimulation group. Results and Conclusions: The investigators will compare the mean baseline and end of treatment Montgomery Asberg depression rating scale between the two groups. The investigators will compare the change in mean depression scores between the baseline and end of treatment in those receiving active t-DCS for a total of 7 weeks duration. This study is innovative and of significance in exploring the role of this novel, easy to administer, safe and cost effective treatment modality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for phase_4 major-depressive-disorder

Timeline
Completed

Started May 2014

Typical duration for phase_4 major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 19, 2014

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2018

Completed
Last Updated

January 12, 2018

Status Verified

January 1, 2018

Enrollment Period

3.7 years

First QC Date

May 15, 2014

Last Update Submit

January 10, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Montgomery Asberg depression rating scale score

    Investigators will measure the changes in Montgomery Asberg depression rating scale scores with trans-cranial direct current stimulation

    6 months

Study Arms (2)

Sham Controlled Arm

SHAM COMPARATOR

The subjects randomized to this group will not receive stimulation daily for four weeks.

Other: Sham Controlled Arm

Transcranial direct current stimulation (t-DCS)

ACTIVE COMPARATOR

The subjects randomized to this group will receive anodal t-DCS stimulation daily for four weeks. The stimulation parameters: current 2 mA continuously for 30 minutes.

Device: Transcranial direct current stimulation (t-DCS)

Interventions

The subjects randomized to this group will receive anodal t-DCS stimulation daily for four weeks. The stimulation parameters: current 2 mA continuously for 30 minutes.

Transcranial direct current stimulation (t-DCS)

The subjects randomized to this group will not receive stimulation daily for four weeks.

Sham Controlled Arm

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects that meet criteria for Major depressive disorder (MDD)
  • ages 21 to 65 years and
  • who are treatment resistant

You may not qualify if:

  • Co-morbid substance abuse in last one month.
  • Psychotropic medication changes in last two weeks.
  • Unstable medical or psychiatric problems that need intensive outpatient or inpatient treatment
  • Patients who are not competent to consent for the study
  • Urine pregnancy test positive
  • Ferromagnetic Implanted devices that use electrical or magnetic currents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univ of Florida

Gainesville, Florida, 32606, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Khurshid Khurshid, M.D

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2014

First Posted

May 19, 2014

Study Start

May 1, 2014

Primary Completion

January 8, 2018

Study Completion

January 8, 2018

Last Updated

January 12, 2018

Record last verified: 2018-01

Locations